Sensei Biotherapeutics (SNSE) has shared an announcement.
Erin Colgan has voluntarily resigned from her roles at Sensei Biotherapeutics, Inc., including her position as Chief Financial Officer, effective April 10, 2024. Her departure is amicable, with no disputes regarding the company’s operations, policies, or practices influencing her decision.
See more insights into SNSE stock on TipRanks’ Stock Analysis page.
